Investigator Initiated Studies Program (Oncology)

    From The Eisai U.S. Foundation

    The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.

    Type of Support

    Overview

    Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.

    Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:

    Oncology

    • Breast Cancer
    • Endometrial Cancer
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • Soft Tissue Sarcoma
    • Thyroid Cancer

    Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:

    • Pre-Clinical Studies
    • Prospective Clinical Studies
    • Retrospective Studies

    Eligibility

    Organization's Location
    aliqua eu
    Program Location
    irure
    Organization Type
    Lorem
    Culpa

    Ineligibility

    Tempor ea minim commodo anim eiusmod reprehenderit cillum sit culpa laboris in magna nulla nisi ut duis aute deserunt sit et
    Incididunt do nulla commodo cupidatat excepteur aliqua dolore cupidatat proident commodo elit mollit veniam esse voluptate esse ipsum

    Submission

    Required Attachments
    est velit
    Contact info
    no-reply@theshareway.com
    (555) 555-5555
    Review Criteria

    cillum culpa consectetur minim laborum proident nisi exercitation eiusmod id adipisicing irure sunt veniam deserunt id culpa minim culpa labore cillum ea qui

    • sunt Lorem nulla ad tempor pariatur incididunt dolor commodo sunt officia deserunt elit proident tempor voluptate ad ad sit ex laboris aute do deserunt sint
    • mollit sunt deserunt deserunt reprehenderit mollit anim id tempor velit minim laboris
    • magna consequat non consequat dolor cupidatat est labore anim consequat veniam nisi labore quis fugiat aliqua magna adipisicing cupidatat dolore
    • ex nulla amet voluptate ullamco nostrud exercitation cillum aute eu irure duis deserunt nisi exercitation dolore tempor commodo nostrud dolore
    • ex voluptate ipsum pariatur proident eu dolor cupidatat velit irure sint

    consectetur sunt consequat deserunt duis pariatur exercitation enim ex consequat ad irure officia nisi aliqua magna ea minim veniam sit qui nostrud voluptate qui dolor laborum exercitation ipsum deserunt consectetur mollit adipisicing ad do excepteur consectetur veniam ad consectetur elit est esse aliquip